OBJECTIVE: To report the prevalence and comparison of cancer-linked health behaviors and identify risk factors associated with unhealthy behavior among adolescent siblings and cancer survivors. METHODS: The Child Health and Illness Profile--Adolescent Edition (CHIP--AE) was completed by 307 survivors and 97 sibling controls 14-20 years of age. RESULTS: Risky behavior ranged from 0.7% to 35.8% for survivors and 1.0% to 41.2% for siblings. Comparisons of sexual behavior, tobacco, alcohol, or illicit drug use utilizing continuous data revealed no differences between groups. Categorically, survivors were less likely to report past smokeless tobacco use or current use of beer/wine or binge drinking (p-values range from .01 to .04). Survivors with better mental health were at lower risk for poor behavioral outcomes. CONCLUSIONS: Adolescent survivors engage in risky health behaviors at rates generally equivalent to their siblings. Aggressive health education efforts should be directed toward this high-risk population.
OBJECTIVE: To report the prevalence and comparison of cancer-linked health behaviors and identify risk factors associated with unhealthy behavior among adolescent siblings and cancer survivors. METHODS: The Child Health and Illness Profile--Adolescent Edition (CHIP--AE) was completed by 307 survivors and 97 sibling controls 14-20 years of age. RESULTS: Risky behavior ranged from 0.7% to 35.8% for survivors and 1.0% to 41.2% for siblings. Comparisons of sexual behavior, tobacco, alcohol, or illicit drug use utilizing continuous data revealed no differences between groups. Categorically, survivors were less likely to report past smokeless tobacco use or current use of beer/wine or binge drinking (p-values range from .01 to .04). Survivors with better mental health were at lower risk for poor behavioral outcomes. CONCLUSIONS: Adolescent survivors engage in risky health behaviors at rates generally equivalent to their siblings. Aggressive health education efforts should be directed toward this high-risk population.
Authors: Lisa S Kahalley; Leslie A Robinson; Vida L Tyc; Melissa M Hudson; Wendy Leisenring; Kayla Stratton; Lonnie Zeltzer; Ann C Mertens; Leslie L Robison; Pamela S Hinds Journal: Nicotine Tob Res Date: 2010-02-12 Impact factor: 5.825
Authors: Natasha Buchanan; Wendy Leisenring; Pauline A Mitby; Anna T Meadows; Leslie L Robison; Melissa M Hudson; Ann C Mertens Journal: Cancer Date: 2009-09-15 Impact factor: 6.860
Authors: Joel Milam; Rhona Slaughter; Kathleen Meeske; Anamara Ritt-Olson; Sandra Sherman-Bien; David R Freyer; Aura Kuperberg; Ann S Hamilton Journal: Psychooncology Date: 2015-08-27 Impact factor: 3.894
Authors: James L Klosky; Kathryn M Russell; Kristin E Canavera; Heather L Gammel; Jason R Hodges; Rebecca H Foster; Gilbert R Parra; Jessica L Simmons; Daniel M Green; Melissa M Hudson Journal: Cancer Prev Res (Phila) Date: 2013-08-27
Authors: Melissa M Hudson; Kevin C Oeffinger; Kendra Jones; Tara M Brinkman; Kevin R Krull; Daniel A Mulrooney; Ann Mertens; Sharon M Castellino; Jacqueline Casillas; James G Gurney; Paul C Nathan; Wendy Leisenring; Leslie L Robison; Kirsten K Ness Journal: J Clin Oncol Date: 2014-12-29 Impact factor: 44.544
Authors: Theresa H M Keegan; Li Tao; Mindy C DeRouen; Xiao-Cheng Wu; Pinki Prasad; Charles F Lynch; Margarett Shnorhavorian; Brad J Zebrack; Roland Chu; Linda C Harlan; Ashley W Smith; Helen M Parsons Journal: J Cancer Surviv Date: 2014-01-10 Impact factor: 4.442
Authors: Margaret Bevans; Areej El-Jawahri; D Kathryn Tierney; Lori Wiener; William A Wood; Flora Hoodin; Erin E Kent; Paul B Jacobsen; Stephanie J Lee; Matthew M Hsieh; Ellen M Denzen; Karen L Syrjala Journal: Biol Blood Marrow Transplant Date: 2016-09-19 Impact factor: 5.742
Authors: S Cristina Oancea; James G Gurney; Kirsten K Ness; Rohit P Ojha; Vida L Tyc; James L Klosky; DeoKumar Srivastava; Dennis C Stokes; Leslie L Robison; Melissa M Hudson; Daniel M Green Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-06-17 Impact factor: 4.254
Authors: P J Hollen; V L Tyc; S V Shannon; S F Donnangelo; W L Hobbie; M M Hudson; M C O'Laughlen; M E Smolkin; G R Petroni Journal: J Cancer Surviv Date: 2013-05-28 Impact factor: 4.442